查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
元基因組的全球市場:市場分析與預測(各用途，各技術，各產品，用戶) - 附執行顧問指南(2025年～2029年)
市場調查報告書
商品編碼
1597903

元基因組的全球市場:市場分析與預測(各用途，各技術，各產品，用戶) - 附執行顧問指南(2025年～2029年)

Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 364 Pages | 商品交期: 最快1-2個工作天內

價格

遺傳學在健康和疾病中的作用直到現在才被人們了解。這些新知識加上成本的下降，正在催生新型基因檢測。宏基因組測試檢查樣本中的所有遺傳物質。在此過程中，這是一種全新的方法，使我們能夠了解傳染病、癌症、抗菌素抗藥性和患者基因組。

本報告提供全球元基因組市場相關調查，提供市場概要，以及各用途，各技術，各產品，用戶趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 總體基因體學是什麼
  • 市場定義
  • 調查手法
  • 觀點:醫療保健和IVD產業
  • 染色體，遺傳基因，表觀遺傳學

第3章 市場概要

  • 市場進入機關
    • 學術研究機關
    • 診斷測試開發商
    • 儀器供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 公共的國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關
  • 總體基因體學應用
  • 臨床產業結構

第4章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素
  • 測量，自動化，診斷趨勢

第5章 總體基因體學的最近的趨勢

第6章 主要企業的簡介

  • Arc Bio
  • BaseClear
  • BGI Genomics Co. Ltd
  • Biome Makers
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • CosmosID
  • Element Biosciences
  • Fusion Genomics.
  • Helix OpCo
  • Illumina
  • Institute for Metagenomics
  • Karius
  • Metabiomics Corp
  • Metagenomi
  • MetaSUB International Consortium
  • Microbiome Insights
  • MicroGenDx
  • Molecular Stethoscope
  • Norgen Biotek Corp.
  • Noscendo
  • Novogene Bioinformatics Technology Co., Ltd.
  • One Codex
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PathoQuest S.A.
  • Perkin Elmer
  • Promega
  • Qiagen
  • Second Genome
  • Siemens Healthineers
  • Sysmex
  • Takara Bio
  • Ultima Genomics
  • Zymo Research Corp

第7章 全球市場規模

  • 全球市場，各國
  • 全球市場，各用途
  • 全球市場，各技術
  • 全球市場，各產品
  • 全球市場，各用戶

第8章 各用途市場規模

  • 臨床
  • 微生物基因體
  • 農業
  • 產業·其他

第9章 各技術市場規模

  • 16srRNA
  • 霰彈槍
  • WGS
  • 其他

第10章 各產品市場規模

  • 設備
  • 試劑·套件
  • 軟體
  • 服務

第11章 用戶市場規模

  • 學術
  • 臨床
  • 製藥
  • 其他

第12章 附錄

Report Overview:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It's a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. And finding new kinds of organisms and pathogens in the process. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What is Metagenomics?
  • 2.2. Market Definition
    • 2.2.1. Revenue Market Size.
    • 2.2.2. Clinical
    • 2.2.3. Microbiome
    • 2.2.4. Agricultural
    • 2.2.5. Environmental & Other
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics
  • 2.5. Chromosomes, Genes and Epigenetics
    • 2.5.1. Chromosomes
    • 2.5.2. Genes
    • 2.5.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Metagenomics Applications
    • 3.2.1. Clinical Metagenomics
    • 3.2.2. Diagnostic Use
    • 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
    • 3.2.4. Antimicrobial Resistance
    • 3.2.5. Managing the Microbiome
    • 3.2.6. Public Health Use
  • 3.3. Clinical Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Approach to Diagnostics
    • 4.1.2. The Aging Effect
    • 4.1.3. The Known and the Unknown
    • 4.1.4. A Research Bonanza
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Lower Costs
    • 4.2.3. Testing usage analysis curtailing growth
    • 4.2.4. Wellness has a downside
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. Delve Bio Showing Delivers Greater Diagnostic Yield
  • 5.3. Sewage metagenomics potentially allows surveillance
  • 5.4. Rapid metagenomics to reduce AMR and sepsis
  • 5.5. UK and U.S. Use Metagenomics for Biothreat Assessment
  • 5.6. Phase Genomics Metagenomics Innovation Award
  • 5.7. New Method for Human Gut Assessment
  • 5.8. Metagenomic sequencing Used for Pneumonia Care
  • 5.9. Sepsis Study Shows Metagenomic Clinical Value
  • 5.10. Delve Bio to Develop Metagenomic Sequencing Dx
  • 5.11. Metagenomics Could be a Game-changer
  • 5.12. Model Predicts Millions of Metagenomic Proteins
  • 5.13. Microbiome Analysis May Yield False Results
  • 5.14. Gut microbiome at center of Parkinson's disease
  • 5.15. MicroGenDx, Evvy Partner for Metagenomic Test
  • 5.16. Diagnostic accuracy of metagenomic NGS
  • 5.17. Metagenomics implicates the gut microbiome
  • 5.18. Charities Award $2M for Metagenomic Pathogen Research
  • 5.19. Cost-effective metagenomic HiFi sequencing
  • 5.20. Microbiome Links Uncovered
  • 5.21. Metagenomi Named an Endpoints 11 Winner
  • 5.22. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

  • 6.1. Arc Bio
  • 6.2. BaseClear
  • 6.3. BGI Genomics Co. Ltd
  • 6.4. Biome Makers
  • 6.5. bioMerieux Diagnostics
  • 6.6. Bio-Rad Laboratories, Inc
  • 6.7. CosmosID
  • 6.8. Element Biosciences
  • 6.9. Fusion Genomics.
  • 6.10. Helix OpCo
  • 6.11. Illumina
  • 6.12. Institute for Metagenomics
  • 6.13. Karius
  • 6.14. Metabiomics Corp
  • 6.15. Metagenomi
  • 6.16. MetaSUB International Consortium
  • 6.17. Microbiome Insights
  • 6.18. MicroGenDx
  • 6.19. Molecular Stethoscope
  • 6.20. Norgen Biotek Corp.
  • 6.21. Noscendo
  • 6.22. Novogene Bioinformatics Technology Co., Ltd.
  • 6.23. One Codex
  • 6.24. OraSure Technologies
  • 6.25. Oxford Nanopore Technologies
  • 6.26. Pacific Biosciences
  • 6.27. PathoQuest S.A.
  • 6.28. Perkin Elmer
  • 6.29. Promega
  • 6.30. Qiagen
  • 6.31. Second Genome
  • 6.32. Siemens Healthineers
  • 6.33. Sysmex
  • 6.34. Takara Bio
  • 6.35. Ultima Genomics
  • 6.36. Zymo Research Corp

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Clinical Market
    • 8.1.1. Table Clinical - by Country
    • 8.1.2. Chart - Clinical Growth
  • 8.2. Microbiome Market
    • 8.2.1. Table Microbiome - by Country
    • 8.2.2. Chart - Microbiome Growth
  • 8.3. Agriculture Market
    • 8.3.1. Table Agriculture - by Country
    • 8.3.2. Chart - Agriculture Growth
  • 8.4. Industrial & Other Market
    • 8.4.1. Table Industrial & Other - by Country
    • 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

  • 9.1. 16srRNA Market
    • 9.1.1. Table 16srRNA - by Country
    • 9.1.2. Chart - 16srRNA Growth
  • 9.2. Shotgun Market
    • 9.2.1. Table Shotgun - by Country
    • 9.2.2. Chart - Shotgun Growth
  • 9.3. WGS Market
    • 9.3.1. Table WGS - by Country
    • 9.3.2. WGS - Growth
  • 9.4. Other Technology Market
    • 9.4.1. Table Other Technology - by Country
    • 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Market Sizes by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Other User Market
    • 11.4.1. Table Other User - by Country
    • 11.4.2. Chart - Other User Growth

12. Appendices

  • 12.1. United States Medicare System: Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: The Base Pairs
  • Table 2: Market Players by Type
  • Table 3: The Different Applications of Metagenomic Testing
  • Table 4: Factors Driving Growth
  • Table 5: Four Factors Limiting Growth
  • Table 6: Seven Key Diagnostic Laboratory Technology Trends
  • Table 7: Global Market by Country
  • Table 8: Global Market by Application
  • Table 9: Global Market by Technology
  • Table 10: Global Market by Product
  • Table 11: Global Market by User
  • Table 12: Clinical Segment by Country
  • Table 13: Microbiome Segment by Country
  • Table 14: Agriculture Segment by Country
  • Table 15: Industrial & Other Segment by Country
  • Table 16 16srRNA Segment by Country
  • Table 17: Shotgun Segment by Country
  • Table 18: WGS Segment by Country
  • Table 19: Other Technology Segment by Country
  • Table 20: Instruments Segment by Country
  • Table 21: Reagents and Kits Segment by Country
  • Table 22: Software Segment by Country
  • Table 23: Services Segment by Country
  • Table 24: Academic Segment by Country
  • Table 25: Clinical Segment by Country
  • Table 26: Pharmaceutical Segment by Country
  • Table 27: Other User Segment by Country
  • Table 28: Clinical Lab Fee Schedule
  • Table 29: The Most Common Assays
  • Table 30: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Health Care Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: DNA Strands and Chromosomes
  • Figure 4: Karyogram of Human Chromosomes
  • Figure 5: Size of Various Genomes
  • Figure 6: The Road to Diagnostics
  • Figure 7: The New Diagnostics
  • Figure 8: The Changing Age of the World Population
  • Figure 9: Health Care Consumption by Age
  • Figure 10: Cancer Incidence - Age at Diagnosis
  • Figure 11: Centralized vs. Decentralized Laboratory Service
  • Figure 12: A Highly Multiplexed Syndromic Testing Unit
  • Figure 13: The Real Cost to Sequence the Human Genome
  • Figure 14: The Codevelopment Process
  • Figure 15: Comparing MDx Diagnostic and Traditional Testing
  • Figure 16: Country Market Shares
  • Figure 17: Application Share by Year
  • Figure 18: Application Segment Growth Rates
  • Figure 19: Segment Share Shifts
  • Figure 20: Application Segment Share Base Year
  • Figure 21: Application Segment Share Final Year
  • Figure 22: Technology Share by Year
  • Figure 23: Technology Segment Growth Rates
  • Figure 24: Technology Segment Share Shifts
  • Figure 25: Technology Segment Share Base Year
  • Figure 26: Technology Segment Share Final Year
  • Figure 27: Product Share by Year
  • Figure 28: Product Segment Growth Rates
  • Figure 29: Product Segment Share Shifts
  • Figure 30: Product Segment Share Base Year
  • Figure 31: Product Segment Share Final Year
  • Figure 32: User Share by Year
  • Figure 33: User Segment Growth Rates
  • Figure 34: User Segment Share Shifts
  • Figure 35: User Segment Share Base Year
  • Figure 36: User Segment Share Final Year
  • Figure 37: Clinical vs. Total Market Growth
  • Figure 38: Microbiome vs. Total Market Growth
  • Figure 39: Agriculture vs. Total Market Growth
  • Figure 40: Industrial & Other vs. Total Market Growth
  • Figure 41 16srRNA vs. Total Market Growth
  • Figure 42: Shotgun vs. Total Market Growth
  • Figure 43: WGS vs. Total Market Growth
  • Figure 44: Other Technology vs. Total Market Growth
  • Figure 45: Instrument vs. Total Market Growth
  • Figure 46: Reagents and Kits vs. Total Market Growth
  • Figure 47: Software vs. Total Market Growth
  • Figure 48: Services vs. Total Market Growth
  • Figure 49: Academic vs. Total Market Growth
  • Figure 50: Clinical vs. Total Market Growth
  • Figure 51: Pharmaceutical vs. Total Market Growth
  • Figure 52: Other User Growth